Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals

In recent years, great progress has been made in the field of new therapeutic options for hepatitis C virus (HCV) infection. The new direct-acting antiviral agents (DAAs) represent a great hope for millions of chronically infected individuals because their use may lead to excellent cure rates with f...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinks, Julieta, Caputo, Mariela, Hulaniuk, María L, Corach, Daniel, Flichman, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378445/
https://www.ncbi.nlm.nih.gov/pubmed/28405170
http://dx.doi.org/10.2147/PGPM.S125452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378445/
https://www.ncbi.nlm.nih.gov/pubmed/28405170
http://dx.doi.org/10.2147/PGPM.S125452

Ejemplares similares